 |
 |
 |
 |
 |
 |
 |
 |
-
BROWSE TOPICS IN CLINICAL MANAGEMENT:
Antiretroviral Therapy- Complications of HIV/HAART
- Research & Development
- Clinical Trials
- Quality of Life & Patient Care
Antiretroviral Therapy
Hepatitis C Research
- Literature Citations for the Incidence and Diagnosis of HIV/Hepatitis C Coinfection (Regularly Updated)
From U.S. National Institutes of Health - Literature Citations for the Treatment of HIV/Hepatitis C Coinfection (Regularly Updated)
From U.S. National Institutes of Health - New Theory Suggests How Hepatitis C May Cause Rare Immune Disease (May 9, 2008)
From Rockefeller University - Hepatitis C: New Treatments in the Pipeline (April 2008)
To read PDF, click here
From Treatment Action Group - CROI: Choice of Nucleoside Analogue in Co-Infection: Tenofovir Associated With Better Response to HCV Therapy (February 15, 2008)
From aidsmap.com - Study Examines Pro-Inflammatory Responses in HIV/HCV-Coinfected Injection Drug Users (February 6, 2008)
From The Body PRO - Higher HCV RNA Levels Associated With Greater Early T-Cell Activation and CD4+ Cell Depletion Among Antiretroviral-Naive, HIV/HCV-Coinfected Patients (February 5, 2008)
From The Body PRO - HIV/HCV-Coinfected Patients Appear More Likely Than HIV-Monoinfected Patients to Develop Insulin Resistance After Initiating HAART (February 5, 2008)
From The Body PRO - HIV/Hepatitis C Coinfection Does Not Influence CD4+ Cell Recovery in Patients on Suppressive HAART (February 5, 2008)
Lars Peters, M.D., discusses his study, which counters long-established assumptions about the effect of HCV/HIV coinfection on immune recovery after patients commence antiretroviral therapy.
From The Body PRO - Rapid Liver Fibrosis Occurring More Frequently Among HIV-Infected Men Newly Coinfected With Hepatitis C (February 4, 2008)
An interview with Daniel Fierer, M.D.
In 15th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - Daily Cannabis Use Associated With Worse Fibrosis in Patients With Chronic Hepatitis C (January 29, 2008)
From aidsmap.com - CD4 Cell Count Is No Predictor of Hepatitis C Treatment Success (January 18, 2008)
From aidsmap.com - First Large Head-to-Head Comparison of Schering and Roche HCV Therapies: Similar Virologic Responses; Fewer Relapses With PegIntron (January 16, 2008)
From aidsmap.com - EACS: Studies Underline the Need for Better Hepatitis C Treatment (November 2, 2007)
From aidsmap.com - Undetectable Viral Load Is Goal for All, Together With Earlier Treatment, Say New European Treatment Guidelines (October 25, 2007)
From aidsmap.com - News From the Front (Fall 2007)
To read PDF, click here
In ACRIA Update, from AIDS Community Research Initiative of America - Routine Hepatitis C Screening Urged for Patients Diagnosed With HIV: Study (September 27, 2007)
In aidsmap.com - Testing Method Could Predict Sustained Virologic Response to HCV Treatment at Four Weeks (August 15, 2007)
From Reuters Health - Rapid and Early Virological Response to Chronic Hepatitis C Treatment With IFN Alpha-2b or PEG-IFN Alpha-2b Plus Ribavirin in HIV/HCV Coinfected Patients (August 2007)
In Gut - SMART Substudy on Hepatitis Coinfection (July 24, 2007)
In The 4th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, from The Body PRO - Hepatitis C Treatment (July 23, 2007)
In The 4th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, from The Body PRO - Sexual Transmission of Hepatitis C (July 23, 2007)
In The 4th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, from The Body PRO - Early HCV Treatment Is Usually Successful in HIV/HCV-Coinfected Gay Men (July 11, 2007)
From aidsmap.com - Study May Disprove Link Between HIV/Hep C Coinfection and Some Metabolic Problems (May 21, 2007)
A pair of new U.S. studies appears to contradict long-held concerns that HIV/hepatitis C-coinfected people have a higher risk of diabetes and lipoatrophy (fat loss).
From aidsmap.com - Acute Hepatitis C Infection in HIV-Infected Men: An Emerging Epidemic (May 2007)
A detailed discussion by Mark Danta, M.D., M.P.H., of the University of New South Wales Australia.
In The PRN Notebook - HCV Relapse Common, Treatment Success Uncertain Following Liver Transplant in HIV/HCV-Coinfected Patients (January 12, 2007)
From aidsmap.com - Cardiovascular Disease Risk Higher Among HIV/HCV-Coinfected Patients (January 11, 2007)
In AIDS - Lipid Abnormalities in HIV/Hepatitis C Virus-Coinfected Patients (November 2006)
In HIV Medicine - HIV/HCV Coinfection Exacerbates ESLD Risk (September 2006)
To read PDF, click here
In IAPAC Monthly, from International Association of Physicians in AIDS Care - Advocacy Groups Charge Schering-Plough With Racial Discrimination for Excluding Blacks From Hepatitis C Trial (April 3, 2006)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Chronic Hepatitis C in the Hispanic Population (March 2006)
To read PDF, click here
From HCV Advocate - Literature Review: Hospitalizations, Expenditures Due to Hepatitis C on the Rise in U.S. (January 2006)
In Infectious Diseases in Corrections Report, from Brown Medical School - Mother-to-Child Hepatitis C Transmission Twice as Likely Among Infant Girls as Boys (December 19, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Ritonavir-Boosted Tipranavir Increases ALT and AST Levels in HIV/Hepatitis-Coinfected Patients (December 16, 2005)
In The 45th Interscience Conference on Antimicrobial Agents and Chemotherapy - Many Infants Acquire Hepatitis C Infection From Infected Mothers in Utero (September 7, 2005)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Study Finds Epoetin Alfa Improves Anemia in HIV/HCV-Coinfected Patients (August 2005)
To read PDF, click here
In IAPAC Monthly, from International Association of Physicians in AIDS Care - Adverse Event Risk on Abacavir + Lamivudine Is Not Higher for Patients Coinfected With Hepatitis B and/or Hepatitis C (July 26, 2005)
In The 3rd International AIDS Society Conference on HIV Pathogenesis and Treatment - Fosamprenavir + Ritonavir Appears Safe Through 120 Weeks in HIV/HBV and HIV/HCV-Coinfected Patients (July 26, 2005)
In The 3rd International AIDS Society Conference on HIV Pathogenesis and Treatment - HIV and Hepatitis C Coinfection: No Increase in HIV Disease Progression (April 2005)
Results from a rather large U.S. study comprised mostly of young women of color.
From The Body PRO - Barriers to Care of HCV for Drug Users: Access Not the Only Problem, Study Suggests (January 2005)
In Infectious Diseases in Corrections Report, from Brown Medical School - HCV Therapy in Coinfected Patients: The Rise of Peginterferon Alfa-2a (January 2005)
Part of HIV JournalView's Top 10 Research Reports of 2004.
From The Body PRO - Hepatitis C Clearance Examined in Injection Drug Users (December 2004)
In Infectious Diseases in Corrections Report, from Brown Medical School - IDSA Conference Highlights: Hepatitis C Mono/Coinfection Seminar (December 2004)
To read PDF, click here
In Infectious Diseases in Corrections Report, from Brown Medical School - Long-Term Outcome Looks Good for Chronic Hepatitis C Patients Receiving Successful Treatment (December 2004)
In Infectious Diseases in Corrections Report, from Brown Medical School - Coinfection With Hepatitis C May Shorten Lives of HIV-Infected People (November 10, 2004)
Among a cohort of 970 HIV-infected U.S. veterans, those with hepatitis C faced a greater risk of death and were less likely to receive HAART.
From aidsmap.com - HIV JournalView: HCV as a Rationale for C-Section in HIV-Infected Pregnant Women (October 2004)
From The Body PRO - High Rate of Relapse Found in HIV/HCV-Coinfected Patients (October 2004)
Quick recap of a study in the journal AIDS Research and Human Retroviruses.
In HIV Treatment ALERTS!, from The Center for AIDS - New Hepatitis C Combo Regimen May Cause Serious Eye Problems (August 26, 2004)
Regular ophthalmologic exams are recommended for HIV/hepatitis C-coinfected patients taking peginterferon alfa-2b (PEG-Intron) and ribavirin.
From aidsmap.com - Both Tenofovir and Stavudine Well Tolerated in HCV-Coinfected Patients (July 12, 2004)
In The XV International AIDS Conference, from The Body PRO - Response to Lopinavir/Ritonavir in HIV-Infected Patients Coinfected With Hepatitis C and/or Hepatitis B (July 12, 2004)
In The XV International AIDS Conference, from The Body PRO - PegIFN/Ribavirin During Acute HCV Coinfection (July 2004)
If tolerated, combination hepatitis C therapy used during the first six months of infection can lead to a high rate of viral clearance in patients coinfected with HIV.
To read PDF, click here
In IAPAC Monthly, from International Association of Physicians in AIDS Care - Hepatitis C Treatment Regimen Far Less Successful Among Black Patients (June 1, 2004)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - The 39th European Association for the Study of the Liver (April 18, 2004)
Browse through the abstracts from this annual meeting.
- CROI 2004 Recap: HIV, HCV and HBV (April 2004)
In IAPAC Monthly, from International Association of Physicians in AIDS Care - HCV and Neuropsychological Impairment (April 2004)
To read PDF, click here
In IAPAC Monthly, from International Association of Physicians in AIDS Care - Results of Three Large HCV Treatment Trials Presented at XI CROI (April 2004)
In TAGline, from Treatment Action Group - Hepatitis C Coinfection Review (March/April 2004)
An overview of the newest treatments and studies.
To read PDF, click here
In Positively Aware, from Test Positive Aware Network - Neopterin a Novel Marker of Immune Function in Hepatitis C (March 2004)
To read PDF, click here
From HCV Advocate - Peginterferon Alfa-2a Plus Ribavirin Found Superior to Peginterferon Alfa-2a Monotherapy and Interferon Plus Ribavirin (February 23, 2004)
From HIV InSite - Liver Transplants Safe, Successful in Otherwise Healthy HIV Patients (February 11, 2004)
In The 11th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - Nelfinavir, Lopinavir/Ritonavir Appear Safe for Hepatitis C Patients (February 10, 2004)
In The 11th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - Hepatitis C May Negatively Impact Neurocognitive Function (February 9, 2004)
In The 11th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - HCV Snapshots: Macro to Micro (October 2003)
HIV/hepatitis C coinfection research from the 9th European AIDS Conference.
In GMHC Treatment Issues, from Gay Men's Health Crisis - 18 Months of HCV Therapy Needed to Prevent High Relapse Rate, Study Finds (September 16, 2003)
From aidsmap.com - HCV Coinfection Associated With an Increased Risk of Diabetes in HIV-Positive U.S. Veterans (September 16, 2003)
From aidsmap.com - Saliva May Have Infectious Amounts of HCV in Presence of High HCV Viral Load and Gum Disease (September 16, 2003)
From aidsmap.com - HAART Often Successful in HIV/HCV Coinfected Patients -- If They Can Stay on Treatment (September 15, 2003)
In The 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, from The Body PRO - Peg-IFN Achieves Poor Results in HIV-HCV Patients Even When Used With Ribavirin (September 15, 2003)
From aidsmap.com - Thymalfasin May Help HCV Patients Who Have Failed Treatment (September 10, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Hepatitis C Found to Diminish Response to HAART (August 12, 2003)
From Canadian AIDS Treatment Information Exchange - Hepatitis C and Cognitive Impairment (August 2003)
To read PDF, click here
From HCV Advocate - Ribapharm Loses Ruling on Hepatitis C Drug; Finding Allows Generic Competition for Ribavirin (July 18, 2003)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Report Questions Early Treatment of Hepatitis C (July 9, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Sniffing/Sorting Cocaine and Heroin May Add to Hepatitis C Risk (July 9, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Latinos and Hepatitis C (June 2003)
To read PDF, click here
From HCV Advocate - Pretreatment of Chronic Active Hepatitis C in Patients Coinfected With HIV and Hepatitis C Virus Reduces the Hepatotoxicity Associated With Subsequent Antiretroviral Therapy (June 1, 2003)
A study suggests that receiving hepatitis C treatment before starting HAART, rather than after, can help reduce liver damage.
In Journal of AIDS - First Clinical Care Options for Hepatitis, June 19-22 (May 30, 2003)
In AIDS Treatment News, from AIDS Treatment News - Asian Americans at High Risk for Hepatitis C Liver Cancer (May 23, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Liver Damage a Concern for HAART Patients With Hepatitis C, Low CD4 (May 1, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Theory Links Hepatitis C to Polio Syringes in Italy (April 30, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Experimental Drugs Block Hepatitis C Virus (April 25, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Genotype, Enzyme Levels, and Viral Load Are Clues to Hepatitis C Virus Outcomes (April 11, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Case Study: 36-Year-Old Male With Hepatitis C and HIV Infection (April 2003)
To read PDF, click here
In HEPP Report, from Brown Medical School - Developing a Systematic Approach to Hepatitis C for Correctional Systems: Controversies and Emerging Consensus (April 2003)
To read PDF, click here
In HEPP Report, from Brown Medical School - Hepatitis C and Fatigue (April 2003)
To read PDF, click here
From HCV Advocate - High-Dose Interferon Effective in Patients Coinfected With Hepatitis C (March 12, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Research and Policy Recommendations for HCV/HIV Coinfection (February 2003)
To read PDF, click here
In TAGline, from Treatment Action Group - Is Hepatitis C Virus Going to Become a Major STD? (December 18, 2002)
From Canadian AIDS Treatment Information Exchange - Bleaching Needles May Help Protect Against Hep C (November 20, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - New York Veterans Suffer High Rates of Hepatitis C With HIV Infection (November 6, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Hepatitis C May Not Progress as Often as Believed (November 1, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - The Role of the Immune System in Determining Viral Outcome After Hepatitis C Viral (HCV) Infection (November 2002)
To read PDF, click here
From HCV Advocate - Hepatitis Worse During Immunocompetence With HIV/Hepatitis C Coinfection (October 9, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - HCV Infection Doesn't Reduce High-Risk Activities in Injection-Drug Users (October 3, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Study: Hepatitis Shots Show Promise (September 26, 2002)
In a recent study, peginterferon alfa-2a plus ribavirin beats the standard hepatitis C treatment.
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Hepatitis C Screening and Management Practices: A Survey of Drug Treatment and Syringe Exchange Programs in New York City (August 13, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Hepatitis C in Vietnam Era Veterans (August 2002)
To read PDF, click here
From HCV Advocate - HIV-Protective Gene May Boost Hepatitis C Infection (July 26, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Some HIV-Positive People at Greater Risk for Liver Problems (July 24, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Chronic Hepatitis C in the Veteran Population (June 2002)
To read PDF, click here
From HCV Advocate - High Hepatitis C Rates in San Francisco Bay Area; University of California Study Finds Possible Links to Herpes, Cocaine Use (April 2, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - A New Look at Liver Toxicity Development During Antiretroviral Therapy Containing Protease Inhibitors in Patients With HIV (March 11, 2002)
To read PDF, click here
In STEP Ezine, from Seattle Treatment Education Project - HIV and Hepatitis C (March 2002)
A review of treatment developments from February's Retrovirus conference.
In Hopkins HIV Report - The Role of Antiviral Therapy in the Natural History of Hepatitis C Fibrosis (February 2002)
To read PDF, click here
From HCV Advocate - Pancreatitis: An Emerging Complication of HCV Treatment in HIV Co-Infected Patients Treated With Didanosine/Stavudine Containing Regimens (December 17, 2001)
In 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2001), from The Body PRO - Anemia Symposium Discusses Relationship With HIV, Cancer, Hepatitis C; Discusses Erythropoietin Use (December 16, 2001)
In 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2001), from The Body PRO - Evaluation of Two Doses of Peginterferon Alfa-2a for the Treatment of Chronic Hepatitis C (CHC) (December 16, 2001)
In 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2001), from The Body PRO - Pathogenesis of Hepatitis C Virus (HCV) in HIV-Positive Patients (December 16, 2001)
In 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2001), from The Body PRO - Early Prediction of Response to 40 kda Peginterferon alfa-2A (Pegasys) Plus Ribavirin in Patients With Chronic Hepatitis C (November 12, 2001)
In 52nd Annual Meeting of the American Association for the Study of Liver Diseases, from The Body PRO - Effect of HAART on Liver-Related Mortality in HIV/HCV Co-Infected Patients (November 12, 2001)
In 52nd Annual Meeting of the American Association for the Study of Liver Diseases, from The Body PRO - The Clinical Significance of Hepatitis C Virus (HCV) in Human Immunodeficiency Virus (HIV) Co-Infection (November 12, 2001)
In 52nd Annual Meeting of the American Association for the Study of Liver Diseases, from The Body PRO - Analysis of 40KDA Peginterferon Alfa-2a (Pegasys) in Combination With Ribavirin, Mycophenolate Mofetil, Amantadine or Amantadine Plus Ribavirin in Patients That Relapsed or Did Not Respond to Rebetron Therapy: A Report of Two Randomized Mulitcenter Effica (November 11, 2001)
In 52nd Annual Meeting of the American Association for the Study of Liver Diseases, from The Body PRO - Treatment With 40KDA Peginterferon Alfa-2a (Pegasys) in Combination With Ribavirin Significantly Enhances Quality of Life Compared With Interferon Alfa-2b Plus Ribavirin (November 11, 2001)
In 52nd Annual Meeting of the American Association for the Study of Liver Diseases, from The Body PRO - HIV and HCV Co-Infection -- Current Status and Future Directions (October 27, 2001)
In 39th Annual Meeting of the Infectious Diseases Society of America, from The Body PRO - Retrospective Review of Nevirapine-Induced Hepatotoxicity in HIV/HCV Co-Infected Patients in a Community Health Center (October 27, 2001)
In 39th Annual Meeting of the Infectious Diseases Society of America, from The Body PRO - HCV: PEG-Interferons -- When to Use Them (October 23, 2001)
In 66th Annual Scientific Meeting of the American College of Gastroenterology, from The Body PRO - Novel Treatments for HCV (October 21, 2001)
In 66th Annual Scientific Meeting of the American College of Gastroenterology, from The Body PRO - Giving Interferon Early: An Improved HCV Treatment? (October 2001)
In HEPP News, from Brown Medical School - Liver Fibrosis in HIV/Hepatitis C Coinfection: HIV Protease Inhibitors May Be Protective (August 24, 2001)
To read PDF, click here
In AIDS Treatment News, from AIDS Treatment News - New Peg-Interferon Results (August 2001)
To read PDF, click here
In Project Inform Perspective, from Project Inform - Pegylated Interferon Plus Ribavirin for the Treatment of Chronic Hepatitis C in HIV-Infected Patients (July 9, 2001)
In The 1st International AIDS Society Conference on HIV Pathogenesis and Treatment, from The Body PRO - Liver Transplants Successful in HIV-Positive People (Summer/Autumn 2001)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation - Non-Injection Drug Users at Risk for HCV (June/July 2001)
In HEPP News, from Brown Medical School - Two Cases of Fatal and Severe Hepatitis Associated With RIF and PZA (May 2001)
In HEPP News, from Brown Medical School - Does HCV Negatively Impact on HIV Disease Progression and Survival? (April 2001)
In GMHC Treatment Issues, from Gay Men's Health Crisis - Hepatitis C (HCV) Co-Infection Is Associated With Increased Morbidity and Mortality Among HIV-Infected Patients (February 7, 2001)
In The 8th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - HCV Co-Infection and Summary Session (State-of-the-Art Lecture) (February 5, 2001)
In The 8th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
  |
  |